Core Insights - IBA has launched myQAMatriXXAiR, the first wireless ionization chamber array for patient-specific quality assurance in particle therapy, enhancing verification for proton and carbon ion treatments and supporting advanced techniques like FLASH and ARC radiotherapy [1][3][5] Company Overview - IBA (Ion Beam Applications S.A.) is a global leader in particle accelerator technology, specializing in proton therapy and other applications, employing approximately 2,100 people worldwide and is based in Louvain-la-Neuve, Belgium [8] Product Features - The myQAMatriXXAiR features 1,521 high-resolution air-vented ionization chambers, providing a complete 2D dose distribution readout within seconds, which enhances confidence and patient safety in complex treatment plans [4] - As the first commercially available wireless detector array for particle therapy PSQA, it simplifies setup, reduces QA time, and integrates easily into existing workflows, while being FLASH-ready for next-generation radiotherapy techniques [5] Industry Impact - The introduction of myQAMatriXXAiR sets a new industry standard for quality assurance in particle therapy, addressing the growing complexity of treatment modalities and ensuring robust, future-proof QA solutions [3][4]